Showing results (1981-1990 of 2,045) with videos related to
Sort By:
Pageof 205
The Oncologist|November 25, 2018
Prognosis of Young Survivors of Gastric Cancer in China and the U.S.: Determining Long-Term Outcomes Based on Conditional SurvivalQi-Yue Chen, Qing Zhong, Wei Wang, et al.Frontiers in Pharmacology|June 11, 2021
Traditional Chinese Medicine Qingre Huoxue Treatment vs. the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled TrialXun Gong, Wei-Xiang Liu, Xiao-Po Tang, et al.Nature Communications|January 7, 2026
Efficacy and safety of low-dose interleukin 2 for Behçet's syndrome: a randomized, placebo-controlled, double-blind, phase 2 clinical trialTian Liu, Wenyan Zhou, Yan Zhu, et al.Cancer|August 20, 2025
Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 studyHui-Jen Tsai, Ming-Huang Chen, Hsiu-Po Wang, et al.Human Molecular Genetics|October 19, 2018
A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomasJeffrey R Gehlhausen, Eric Hawley, Benjamin Mark Wahle, et al.World Journal of Pediatrics : WJP|January 23, 2025
Could physical activity promote indicators of physical and psychological health among children and adolescents? An umbrella review of meta-analyses of randomized controlled trialsShan Cai, Huan Wang, Yi-Hang Zhang, et al.Circulation. Arrhythmia and Electrophysiology|November 29, 2024
Pulsed Field Ablation of Paroxysmal Supraventricular Tachycardia: A Prospective Multicenter Single-Arm Study in ChinaFanghui Li, Aobo Gong, Hongde Hu, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|April 25, 2022
The Impact of Traditional Chinese Medicine QingreHuoxue Treatment and the Combination of Methotrexate and Hydroxychloroquine on the Radiological Progression of Active Rheumatoid Arthritis: A 52-Week Follow-Up of a Randomized Controlled Clinical StudyRouman Zhang, Xiao-Po Tang, Jian Wang, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 20, 2024
Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trialNarikazu Boku, Takeshi Omori, Kohei Shitara, et al.Cell Stem Cell|February 15, 2025
PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1Juyeong Hong, Pinpin Sui, Ying Li, et al.Pageof 205